GO:0006225 UDP biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006225 (UDP biosynthetic process) describes the chemical reactions and pathways that form uridine 5'-diphosphate (UDP), a central nucleotide intermediate.
• UDP is a precursor for UDP-glucose, UDP-N-acetylgalactosamine, and other sugar nucleotides that feed into glycosylation, hyaluronan synthesis, and peptidoglycan biosynthesis.
• The pathway intersects with liver glucose metabolism, where UDP-glucose serves as the activated donor for glycogen synthesis.
• UDP and its derivatives are critical for extracellular matrix assembly, immune signaling, and microbial cell wall formation.
• Dysregulation of UDP biosynthesis has been linked to metabolic disorders, cancer, and neuroinflammatory conditions.
• CRISPR-based knockout, knock-in, and overexpression models enable precise dissection of UDP biosynthetic enzymes in health and disease.
Description
UDP biosynthetic process (GO:0006225) is defined as the chemical reactions and pathways resulting in the formation of UDP, uridine (5'-)diphosphate. UDP is a pyrimidine nucleotide that serves as an essential substrate for numerous glycosyltransferases and is a key node in cellular energy metabolism and macromolecular biosynthesis. The pathway is conserved across prokaryotes and eukaryotes, reflecting its fundamental role in nucleotide sugar metabolism. In humans, UDP biosynthesis is tightly coupled to glucose metabolism, as UDP-glucose is generated from glucose-1-phosphate and UTP, linking carbohydrate availability to glycogen and glycosaminoglycan production. Beyond its role in energy storage, UDP is a precursor for UDP-glucuronate, UDP-N-acetylgalactosamine, and other nucleotide sugars that are required for protein glycosylation, proteoglycan synthesis, and cell wall assembly in bacteria. Consequently, researchers studying metabolic disorders, cancer, and infectious diseases frequently investigate UDP biosynthetic enzymes as potential therapeutic targets.
UDP biosynthetic process At A Glance
| GO ID | GO:0006225 |
|---|---|
| GO term | UDP biosynthetic process |
| Ontology | biological_process |
| Synonym | UDP anabolism, UDP biosynthesis, UDP formation, UDP synthesis |
| Major function | Production of UDP, a key nucleotide sugar donor and precursor for UTP and glycosylation reactions |
| Key enzymes | UMP kinase, nucleoside diphosphate kinase, uridine kinase, UDP-glucose pyrophosphorylase |
| Pathway context | Pyrimidine metabolism; nucleotide sugar metabolism; glycogen synthesis; hyaluronan synthesis |
| Cellular location | Cytoplasm |
| Related diseases | Metabolic disorders, cancer, neuroinflammation, bacterial infections |
What Is GO:0006225?
UDP biosynthetic process (GO:0006225) encompasses the enzymatic steps that produce uridine 5'-diphosphate from precursor molecules. This includes the phosphorylation of UMP to UDP by UMP kinases, as well as the interconversion of UDP from UTP via nucleoside diphosphate kinases. The term also covers the formation of UDP from uridine through salvage pathways involving uridine kinase and nucleoside diphosphate kinase. UDP is a branch-point metabolite that can be further converted to UTP or used as a substrate for glycosyltransferases, making its biosynthesis central to nucleotide sugar metabolism.
Why Is UDP biosynthetic process Important in Cell Biology?
UDP biosynthetic process is fundamental to cellular metabolism because UDP serves as the activated form of uridine for glycosylation reactions and as a precursor to UTP, which is required for RNA synthesis and energy transfer. In liver, UDP-glucose is the direct donor for glycogen synthesis, linking UDP biosynthesis to glucose homeostasis. In the extracellular matrix, UDP-glucuronate and UDP-N-acetylgalactosamine are essential for hyaluronan and proteoglycan production, influencing tissue remodeling and cancer progression. In bacteria, UDP-N-acetylgalactosamine is a building block for peptidoglycan, making the pathway a target for antibiotic development. Furthermore, microglial UDP signaling through P2Y6 receptors modulates phagocytosis and neuroinflammation, highlighting its role in brain immunity. Thus, understanding UDP biosynthesis offers insights into diverse physiological and pathological processes.
• Provides UDP-glucose for glycogen synthesis in liver and muscle.
• Supplies UDP-glucuronate for hyaluronan and glycosaminoglycan synthesis.
• Generates UDP-N-acetylgalactosamine for peptidoglycan biosynthesis in bacteria.
• Links glucose metabolism to nucleotide sugar production.
• Modulates immune responses via UDP-mediated P2Y6 receptor signaling in microglia.
• Contributes to cancer cell metabolic reprogramming and immune evasion.
• Essential for protein glycosylation and cell surface receptor function.
• Target for antibacterial drug discovery.
• Involved in neuroinflammatory and epileptogenic processes.
• Potential biomarker for metabolic disorders and cancer.
What Happens During UDP biosynthetic process?
De novo synthesis of UMP
In simple terms: The cell builds UMP from scratch using simple molecules.
The de novo pyrimidine biosynthetic pathway culminates in the formation of UMP, which is the first pyrimidine nucleotide. This pathway involves six enzymatic steps starting from carbamoyl phosphate and aspartate, and is regulated by feedback inhibition. UMP is subsequently phosphorylated to UDP by UMP kinase.
Phosphorylation of UMP to UDP
In simple terms: UMP gets a phosphate group added to become UDP.
UMP kinase catalyzes the ATP-dependent phosphorylation of UMP to UDP. This step is essential for balancing pyrimidine nucleotide pools and is subject to allosteric regulation by downstream nucleotides such as UTP and CTP.
Salvage pathway from uridine
In simple terms: The cell recycles uridine to make UDP.
Uridine can be salvaged from extracellular sources or from RNA turnover. Uridine kinase phosphorylates uridine to UMP, which is then converted to UDP by UMP kinase. Alternatively, uridine can be directly phosphorylated to UDP by uridine kinase in some organisms.
Interconversion of UDP and UTP
In simple terms: UDP and UTP can be converted into each other.
Nucleoside diphosphate kinase reversibly transfers a phosphate from ATP to UDP, forming UTP. Conversely, UTP can be hydrolyzed to UDP by nucleoside triphosphate pyrophosphatases. This interconversion maintains the cellular balance of uridine nucleotides.
Formation of UDP-sugars
In simple terms: UDP is used to carry sugars for building complex molecules.
UDP serves as a substrate for UDP-glucose pyrophosphorylase, which converts glucose-1-phosphate and UTP to UDP-glucose and pyrophosphate. UDP-glucose is then oxidized to UDP-glucuronate by UDP-glucose dehydrogenase, a key step in glycosaminoglycan synthesis. Similarly, UDP-N-acetylgalactosamine is synthesized from glucosamine-6-phosphate in certain archaea and bacteria.
Key Genes Involved in GO:0006225 UDP biosynthetic process
The following genes encode enzymes and transporters directly involved in UDP biosynthetic process and its downstream utilization.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UMPS | Uridine monophosphate synthetase; catalyzes final steps of de novo UMP synthesis | Target for cancer chemotherapy and metabolic studies |
| UMPK | UMP kinase; phosphorylates UMP to UDP | Regulates pyrimidine nucleotide balance; potential drug target |
| NME1 | Nucleoside diphosphate kinase; interconverts UDP and UTP | Involved in metastasis suppression and nucleotide homeostasis |
| UCK1 | Uridine-cytidine kinase 1; salvages uridine to UMP | Linked to nucleoside analog activation in cancer therapy |
| UCK2 | Uridine-cytidine kinase 2; mitochondrial salvage enzyme | Role in mitochondrial nucleotide metabolism |
| UGP2 | UDP-glucose pyrophosphorylase; synthesizes UDP-glucose from UTP and glucose-1-phosphate | Critical for glycogen synthesis and glycosylation |
| UGDH | UDP-glucose dehydrogenase; oxidizes UDP-glucose to UDP-glucuronate | Key enzyme in hyaluronan and proteoglycan synthesis |
| GALE | UDP-galactose-4-epimerase; interconverts UDP-galactose and UDP-glucose | Involved in galactosemia and glycosylation disorders |
| GALK1 | Galactokinase; produces galactose-1-phosphate for UDP-sugar synthesis | Mutations cause galactosemia type II |
| PGM1 | Phosphoglucomutase 1; converts glucose-6-phosphate to glucose-1-phosphate | Links glycolysis to UDP-glucose synthesis |
| PYGL | Glycogen phosphorylase; releases glucose-1-phosphate from glycogen | Regulates substrate availability for UDP-glucose |
| P2RY6 | P2Y6 receptor; responds to UDP to trigger phagocytosis | Modulates microglial neuroinflammation |
| HAS1 | Hyaluronan synthase 1; uses UDP-glucuronate and UDP-N-acetylglucosamine | Isoform-specific roles in matrix biology |
| HAS2 | Hyaluronan synthase 2; major hyaluronan producer | Overexpressed in many cancers |
| HAS3 | Hyaluronan synthase 3; produces shorter hyaluronan chains | Involved in inflammation and cancer |
| UAP1 | UDP-N-acetylglucosamine pyrophosphorylase; synthesizes UDP-GlcNAc | Essential for protein O-GlcNAcylation |
| GFPT1 | Glutamine-fructose-6-phosphate transaminase 1; rate-limiting for UDP-GlcNAc synthesis | Target for metabolic and neuromuscular disorders |
How Is UDP biosynthetic process Regulated?
UDP biosynthetic process is regulated at multiple levels. The de novo pyrimidine pathway is feedback-inhibited by UTP and CTP, ensuring balanced nucleotide pools. UMP kinase activity is allosterically controlled by GTP and UTP. In liver, insulin and glucagon modulate the expression and activity of enzymes such as UDP-glucose pyrophosphorylase, linking UDP biosynthesis to glucose homeostasis. Hyaluronan synthases, which consume UDP-sugars, are regulated by metabolic cues including AMPK and mTOR signaling. Additionally, microglial P2Y6 receptor signaling is modulated by UDP availability, influencing neuroinflammatory responses.
UDP biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UGDH | Cancer progression, hyaluronan synthesis | Knockout in cancer cell lines; xenograft models |
| P2RY6 | Epileptogenesis, neuroinflammation | Microglial-specific knockout mice; seizure models |
| UGP2 | Glycogen storage disease, metabolic myopathy | Liver-specific knockout mice; patient-derived iPSCs |
| GALE | Galactosemia, glycosylation defects | Knock-in of patient mutations in cell lines |
| UAP1 | O-GlcNAcylation, cancer metabolism | Overexpression and knockout in cancer cells |
UDP biosynthesis in cancer metabolism
Cancer cells often reprogram nucleotide metabolism to support rapid proliferation. UDP-glucose dehydrogenase (UGDH) is upregulated in several cancers and promotes hyaluronan synthesis, which enhances tumor growth and metastasis. Targeting UGDH or hyaluronan synthases has been proposed as a therapeutic strategy. Furthermore, the metabolic axis involving UDP-sugars contributes to immune evasion in tumors.
Neuroinflammation and epilepsy
UDP acts as a danger signal that activates microglial P2Y6 receptors, triggering phagocytosis and shaping neuroimmune responses. In epileptogenesis, microglial P2Y6 calcium signaling promotes phagocytosis of synapses and contributes to neuronal circuit remodeling. Dysregulated UDP biosynthesis may therefore influence seizure susceptibility and neuroinflammation.
Metabolic disorders and glycogen storage
UDP-glucose is the direct precursor for glycogen synthesis. Deficiencies in enzymes that supply or utilize UDP-glucose, such as phosphoglucomutase 1 and UDP-glucose pyrophosphorylase, lead to glycogen storage diseases and exercise intolerance. Additionally, galactosemia results from defects in UDP-galactose interconversion, highlighting the importance of UDP-sugar metabolism.
Bacterial infections and antibiotic targets
In bacteria, UDP-N-acetylgalactosamine is a key precursor for peptidoglycan biosynthesis, which is essential for cell wall integrity. Enzymes in this pathway are attractive targets for novel antibiotics. The direct biosynthetic pathway from glucosamine-6-phosphate to UDP-N-acetylgalactosamine in thermophilic archaea underscores the diversity of microbial UDP-sugar synthesis.
From UDP biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does UGDH loss reduce hyaluronan synthesis? | UGDH knockout cancer cell line |
| Does P2Y6 receptor activation enhance microglial phagocytosis? | P2ry6 knockout mouse; primary microglia |
| Can a point mutation in UGP2 mimic glycogen storage disease? | Knock-in of patient mutation in HepG2 cells |
| Does overexpression of HAS2 increase tumor growth? | HAS2 overexpression in breast cancer cells; xenograft |
| Is UDP-N-acetylgalactosamine synthesis essential for bacterial viability? | CRISPR interference knockdown in E. coli |
| Does UMPK inhibition alter nucleotide pools? | UMPK knockout in leukemia cell lines |
How to Study the UDP biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | UDP and related nucleotide levels | Quantifying pathway flux in knockout cells |
| Enzyme-coupled spectrophotometry | Activity of UMP kinase or UGDH | Kinetic studies and inhibitor screening |
| CRISPR knockout library screening | Genes essential for UDP biosynthesis | Identifying synthetic lethal targets |
| RNA-seq | Transcriptional changes in UDP pathway genes | Evaluating metabolic reprogramming |
| Western blot | Protein expression of UDP enzymes | Validating knockout or overexpression |
| Fluorescence microscopy | Subcellular localization of UDP-sugar sensors | Live-cell imaging of UDP dynamics |
| Glycosaminoglycan quantification | Hyaluronan or proteoglycan production | Assessing downstream UDP-sugar utilization |
Metabolomics and nucleotide profiling
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) enables quantification of UDP and other nucleotides from cell extracts. This method is used to assess how genetic perturbations affect UDP biosynthetic flux.
Enzyme activity assays
Recombinant enzymes such as UMP kinase or UDP-glucose dehydrogenase can be assayed spectrophotometrically by monitoring NADH production or ATP consumption. These assays help determine kinetic parameters and inhibitor efficacy.
CRISPR screening for pathway genes
Genome-wide CRISPR knockout screens can identify genes required for UDP biosynthesis under specific conditions, such as glucose deprivation or drug treatment. Hits are validated by targeted knockout and metabolite rescue.
Imaging of UDP-sugar utilization
Fluorescently labeled UDP-sugar analogs or genetically encoded biosensors can visualize UDP-glucose dynamics in live cells. These tools reveal spatiotemporal regulation of UDP biosynthesis.
How CRISPR Can Be Used to Study GO:0006225 UDP biosynthetic process
Knockout
CRISPR-Cas9 knockout of genes such as UGDH, UGP2, or UMPK creates cell models to study loss-of-function phenotypes. These models are used to determine whether UDP biosynthetic enzymes are required for proliferation, glycosylation, or stress responses.
Point Mutation
Introducing patient-derived point mutations (e.g., in GALE or UGP2) via CRISPR base editing or homology-directed repair allows researchers to dissect the molecular consequences of specific amino acid changes on enzyme activity and UDP production.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous UDP biosynthetic genes enables real-time tracking of protein localization and interaction. This approach is valuable for studying dynamic regulation of the pathway.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like HAS2 or UGDH can boost UDP-sugar utilization and hyaluronan production. These models are used to investigate oncogenic roles of UDP metabolism.
How EDITGENE Supports UDP biosynthetic process Research
Researchers studying UDP biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in metabolite production, disease progression, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of UDP pathway components.
Contact EDITGENE today to design your custom CRISPR model for UDP biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| AK9 Knockout HEK293 Cell Line | EDJ-KQ8808 | Human | 221264 | Details Get a Quote |
| AK9 Knockout A-549 Cell Line | EDJ-KQ35107 | Human | 221264 | Details Get a Quote |
| AK9 Knockout HCT 116 Cell Line | EDJ-KQ35108 | Human | 221264 | Details Get a Quote |
| AK9 Knockout HeLa Cell Line | EDJ-KQ35109 | Human | 221264 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records
Frequently Asked Questions About UDP biosynthetic process
What is UDP biosynthetic process?
UDP biosynthetic process (GO:0006225) is the set of chemical reactions that produce uridine 5'-diphosphate (UDP), a key nucleotide involved in glycosylation and energy metabolism.
What genes are involved in UDP biosynthetic process?
Key genes include UMPS, UMPK, NME1, UCK1, UGP2, UGDH, and GALE, which encode enzymes for UMP synthesis, phosphorylation, and UDP-sugar interconversion.
How is UDP synthesized in cells?
UDP is synthesized by phosphorylation of UMP via UMP kinase or by salvage of uridine through uridine kinase and nucleoside diphosphate kinase.
What is the role of UDP in glycogen synthesis?
UDP-glucose, derived from UDP, is the direct donor for glycogen synthesis in liver and muscle.
Which diseases are linked to UDP biosynthesis?
Dysregulated UDP biosynthesis is associated with cancer, neuroinflammation, glycogen storage diseases, and galactosemia.
How can CRISPR be used to study UDP biosynthesis?
CRISPR knockout, knock-in, and overexpression models allow researchers to test the function of UDP pathway genes in cell lines and animal models.
What is the connection between UDP and hyaluronan?
UDP-glucuronate and UDP-N-acetylglucosamine are substrates for hyaluronan synthases, linking UDP biosynthesis to extracellular matrix production.
Is UDP involved in immune signaling?
Yes, UDP activates P2Y6 receptors on microglia, promoting phagocytosis and modulating neuroinflammation.
What methods are used to measure UDP levels?
LC-MS/MS metabolomics and enzyme-coupled assays are commonly used to quantify UDP and related nucleotides.
Why is UDP biosynthesis a drug target?
Enzymes in this pathway are essential for bacterial cell wall synthesis and cancer cell proliferation, making them attractive targets for antibiotics and anticancer drugs.
Conclusion
UDP biosynthetic process (GO:0006225) is a central metabolic pathway that supplies UDP for glycosylation, glycogen synthesis, and extracellular matrix production. Its dysregulation contributes to cancer, neuroinflammation, and metabolic disorders, making it a rich area for therapeutic investigation. Advances in CRISPR-based gene editing and metabolomics now enable precise dissection of UDP pathway enzymes in physiologically relevant models. EDITGENE's comprehensive services support researchers in generating knockout, knock-in, and overexpression models to accelerate discoveries in UDP biology.
References
- 1. Adeva-Andany MM et al.. 2016. Liver glucose metabolism in humans.. Biosci Rep 36(6) PMID: 27707936
- 2. Umpierre AD et al.. 2024. Microglial P2Y(6) calcium signaling promotes phagocytosis and shapes neuroimmune responses in epileptogenesis.. Neuron 112(12):1959-1977.e10 PMID: 38614103
- 3. Chen J et al.. 2019. Catalytic mechanism of UDP-glucose dehydrogenase.. Biochem Soc Trans 47(3):945-955 PMID: 31189734
- 4. Caon I et al.. 2021. Cell Energy Metabolism and Hyaluronan Synthesis.. J Histochem Cytochem 69(1):35-47 PMID: 32623953
- 5. Vigetti D et al.. 2014. Metabolic control of hyaluronan synthases.. Matrix Biol 35:8-13 PMID: 24134926
- 6. Dadashipour M et al.. 2018. Identification of a Direct Biosynthetic Pathway for UDP-N-Acetylgalactosamine from Glucosamine-6-Phosphate in Thermophilic Crenarchaeon Sulfolobus tokodaii.. J Bacteriol 200(10) PMID: 29507091
- 7. Barreteau H et al.. 2008. Cytoplasmic steps of peptidoglycan biosynthesis.. FEMS Microbiol Rev 32(2):168-207 PMID: 18266853
- 8. Hinshaw DC et al.. 2024. A Metabolic Axis of Immune Intractability.. Cancer Immunol Res 12(3):282-286 PMID: 38126910
